Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema

NCT02036424 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDIV

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ozurdex
DRUG: Bevacizumab

Sponsor

Raj K. Maturi, MD

Collaborators

[object Object]